← FDA Drug Approvals (Drugs@FDA)

LEVETIRACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS · Approved 2013-06-26

Drug application

FDA Application #

ANDA091627

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVETIRACETAM

Generic name

LEVETIRACETAM

Active ingredients

LEVETIRACETAM

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

SAGENT PHARMS

Manufacturer

Sagent Pharmaceuticals

First approval

2013-06-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown